2024 ´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-15
±³À°ÀÏÀÚ : 2024-06-15
±³À°Àå¼Ò : ¼¼Á¾´ëÇб³ ±¤°³Åä°ü
±³À°ÁÖÁ¦ : 2024 ´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ Ãá°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581
À̸ÞÀÏ : kspho@kams.or.kr
±³À°Á¾·ù : ¼Ò¾Æû¼Ò³â°ú
Âü¼®¿¹»óÀÎ : 70¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í Àü¹®ÀÇ 50,000¿ø, Àü°øÀÇ/°£È£»ç/ 30,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06¿ù 15ÀÏ ROOM 1 10:00~10:30 Genomic landscape of IBMFS(Inherited Bone Marrow Failure Syndromes) ±èº¸¶÷(¼º±Õ°üÀÇ´ë )
±³À°½Ã°£ 06¿ù 15ÀÏ ROOM 1 10:30~11:00 Treatment and long-term management of IBMFS(Inherited Bone Marrow Failure Syndromes) beyond transplantation ±èº¸¶÷(Àü³²ÀÇ´ë )
±³À°½Ã°£ 06¿ù 15ÀÏ ROOM 1 11:00~11:30 Recent advances in treatment of severe aplastic anemia À¯Àç¿ø(°¡Å縯ÀÇ´ë )
±³À°½Ã°£ 06¿ù 15ÀÏ ROOM 1 11:50~12:10 systemic mastocytosis associated hematologic malignancy °¼ºÇÑ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 06¿ù 15ÀÏ ROOM 1 12:10~12:30 Surveillance Strategies for Germline RB1 Gene Mutation. ¾È¿ø±â(¿¬¼¼ÀÇ´ë )
±³À°½Ã°£ 06¿ù 15ÀÏ ROOM 1 14:00~14:30 Pediatric-inspired ALL(acute lymphoblastic leukemia) treatment in AYA patients ±èº¸°æ(¼¿ïÀÇ´ë )
±³À°½Ã°£ 06¿ù 15ÀÏ ROOM 1 14:30~15:00 Acute myeloid leukemia in adolescent and young adult patiens À̳ªÈñ(Â÷ÀÇ°úÇдë)
±³À°½Ã°£ 06¿ù 15ÀÏ ROOM 1 15:00~15:30 Special needs in AYA cancer patients ÀÓ¿¬Á¤(Ãæ³²ÀÇ´ë )
±³À°½Ã°£ 06¿ù 15ÀÏ ROOM 1 16:00~16:30 STREAM program: precision medicine platform in pediatric solid tumor ÀÌÁö¿ø(¼º±Õ°üÀÇ´ë )
±³À°½Ã°£ 06¿ù 15ÀÏ ROOM 1 16:30~17:00 Novel therapeutic agents in pediatric solid tumor ÃÖÁ¤À±(¼¿ïÀÇ´ë )
±³À°½Ã°£ 06¿ù 15ÀÏ ROOM 1 17:20~17:50 Palliative care for children with cancer and their families ±Ç½Â¿¬(¿¬¼¼ÀÇ´ë )